Dishman to make API for Janssen; CPhI award winner finalists announced; Ashland to split;

> Ashland Chemical will divide into two publicly traded companies, one that will manufacture chemicals for pharma and other industries and one that will sell its Valvoline engine products. Release

> India's Dishman Pharmaceuticals and Chemicals said it has been selected by Johnson & Johnson's ($JNJ) Janssen Pharmaceutical to produce the active ingredient for its TB drug Sirturo. Report

> CPhI Worldwide has named the finalists in 7 categories for its annual Pharma Awards, including Catalent ($CTLT), TraceLink, Codexis and others, with winners to be selected Oct. 13 during the annual meeting this year in Madrid. Release

> Nigerian officials have said if they can get an investment of $3 million to $5 million, the country has the capability of producing Coralmyn, the antivenom for coral snake bites that is in short supply. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.